Thus, all of these findings suggest that C‐6‐S can be a significant promoter of the anti‐inflammatory activity of IL‐10 in the tumor microenvironment, thereby preventing the initiation of a tumor or supporting the progression of an established tumor. Here, IL10 is linked to neoplasm.